GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Mar 19, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Mar 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on March 19, 2025, that it repurchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine filing reporting on share transactions, not indicating new material risks.
Key Players & Entities
- GSK plc (company) — Registrant
- Citigroup Global Markets Limited (company) — Corporate stockbroker for share repurchases
- March 2025 (date) — Reporting period for the transaction
- March 19, 2025 (date) — Date of the announcement and purchase
FAQ
What was the specific number of GSK plc ordinary shares purchased?
The filing states that GSK plc purchased 'the following number of the Company's ordinary shares' but does not specify the exact quantity in the provided text.
What was the total dollar amount spent on the share repurchases?
The filing does not disclose the total dollar amount spent on the share repurchases.
Who acted as GSK's corporate stockbroker for these transactions?
Citigroup Global Markets Limited acted as GSK's corporate stockbroker for these transactions.
On what date did GSK plc announce the transaction in its own shares?
GSK plc announced the transaction on March 19, 2025.
What is the par value of GSK plc's ordinary shares?
The ordinary shares of GSK plc have a par value of 31¼ pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 19, 2025 regarding GSK plc (GLAXF).